NCT06480994 Exclusion of Venous Thrombo-Embolism With a New Clinical Decision Support
| NCT ID | NCT06480994 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Diagnostica Stago R&D |
| Condition | Venous Thromboembolism |
| Study Type | OBSERVATIONAL |
| Enrollment | 1,836 participants |
| Start Date | 2022-06-21 |
| Primary Completion | 2026-04 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 1,836 participants in total. It began in 2022-06-21 with a primary completion date of 2026-04.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this non interventional study is to demonstrate the diagnostic performances on fresh plasmas in comparison with the performances on frozen plasmas in any patients with VTE suspicion, whatever the pre-test probability. The main question it aims to answer is : Are the performances equivalent on fresh plasmas in comparison with frozen plasmas or is it necessary to determine a new algorithm of the Clinical Decision Support with a new cut-off? Participants will be diagnosed and treated in accordance with routine standard of care.
Eligibility Criteria
Inclusion Criteria: * PE and/or DVT suspicion * No opposition after informing the patient for his participation in research and processing of their data for this purpose, * Benefiting from the social security system Exclusion Criteria: * Preventive or curative anticoagulant treatment, or fibrinolytic treatment, * Legal protection (e.g. guardianship or curatorship), * Pregnant or breastfeeding women.
Contact & Investigator
VINCENT VIOLEAU
PRINCIPAL INVESTIGATOR
Centre Hospitalier de Niort
Frequently Asked Questions
Who can join the NCT06480994 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Venous Thromboembolism. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06480994 currently recruiting?
Yes, NCT06480994 is actively recruiting participants. Contact the research team at aurelie.lamielle@stago.com for enrollment information.
Where is the NCT06480994 trial being conducted?
This trial is being conducted at Niort, France, Le Mans, France, Dijon, France, Grenoble, France.
Who is sponsoring the NCT06480994 clinical trial?
NCT06480994 is sponsored by Diagnostica Stago R&D. The principal investigator is VINCENT VIOLEAU at Centre Hospitalier de Niort. The trial plans to enroll 1,836 participants.